| mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
8e-09 |
| mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
3e-08 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-06 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
7e-06 |
| mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
8e-06 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
3e-05 |
| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |